Insiders · Profile

Cohen Mark S

Director at Akari Therapeutics. Filing since 18 Sep 2015. CIK 0001622779

Company

Date

Role

Action

Shares

Amount

Of holding

AKTX Akari Therapeutics Plc

18 Sep 2015

Director

Bought

1,055,600

$200.04K

opened

1 decision on file.